nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0558	0.174	CbGbCtD
Mirtazapine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0464	0.145	CbGbCtD
Mirtazapine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0389	0.122	CbGbCtD
Mirtazapine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0371	0.116	CbGbCtD
Mirtazapine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0243	0.076	CbGbCtD
Mirtazapine—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0235	0.0733	CbGbCtD
Mirtazapine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0226	0.0707	CbGbCtD
Mirtazapine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0182	0.0567	CbGbCtD
Mirtazapine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0167	0.052	CbGbCtD
Mirtazapine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0104	0.0324	CbGbCtD
Mirtazapine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0102	0.0319	CbGbCtD
Mirtazapine—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.00999	0.0907	CbGeAlD
Mirtazapine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00951	0.0297	CbGbCtD
Mirtazapine—HTR3A—vagus nerve—peripheral nervous system neoplasm	0.00847	0.0769	CbGeAlD
Mirtazapine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00649	0.0203	CbGbCtD
Mirtazapine—HTR3A—cranial nerve—peripheral nervous system neoplasm	0.00645	0.0586	CbGeAlD
Mirtazapine—HTR7—vagus nerve—peripheral nervous system neoplasm	0.00548	0.0498	CbGeAlD
Mirtazapine—HTR7—cranial nerve—peripheral nervous system neoplasm	0.00417	0.0379	CbGeAlD
Mirtazapine—HTR7—pons—peripheral nervous system neoplasm	0.00412	0.0375	CbGeAlD
Mirtazapine—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00365	0.0332	CbGeAlD
Mirtazapine—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00342	0.031	CbGeAlD
Mirtazapine—HTR3A—nerve—peripheral nervous system neoplasm	0.00331	0.03	CbGeAlD
Mirtazapine—HTR3A—ganglion—peripheral nervous system neoplasm	0.00326	0.0296	CbGeAlD
Mirtazapine—HRH3—brainstem—peripheral nervous system neoplasm	0.00296	0.0269	CbGeAlD
Mirtazapine—SLC6A3—nerve—peripheral nervous system neoplasm	0.00275	0.025	CbGeAlD
Mirtazapine—SLC6A3—ganglion—peripheral nervous system neoplasm	0.00272	0.0247	CbGeAlD
Mirtazapine—HTR2C—ganglion—peripheral nervous system neoplasm	0.00263	0.0238	CbGeAlD
Mirtazapine—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.0026	0.0236	CbGeAlD
Mirtazapine—HTR2A—pons—peripheral nervous system neoplasm	0.00257	0.0234	CbGeAlD
Mirtazapine—SLC6A4—ganglion—peripheral nervous system neoplasm	0.00249	0.0226	CbGeAlD
Mirtazapine—SLC6A2—nerve—peripheral nervous system neoplasm	0.00222	0.0202	CbGeAlD
Mirtazapine—HTR1A—ganglion—peripheral nervous system neoplasm	0.00221	0.0201	CbGeAlD
Mirtazapine—SLC6A2—ganglion—peripheral nervous system neoplasm	0.00219	0.0199	CbGeAlD
Mirtazapine—HTR7—nerve—peripheral nervous system neoplasm	0.00214	0.0194	CbGeAlD
Mirtazapine—HTR7—ganglion—peripheral nervous system neoplasm	0.00211	0.0192	CbGeAlD
Mirtazapine—DRD2—nerve—peripheral nervous system neoplasm	0.00202	0.0184	CbGeAlD
Mirtazapine—DRD2—ganglion—peripheral nervous system neoplasm	0.002	0.0181	CbGeAlD
Mirtazapine—HTR3A—trigeminal ganglion—peripheral nervous system neoplasm	0.0016	0.0146	CbGeAlD
Mirtazapine—HRH3—cerebellum—peripheral nervous system neoplasm	0.00146	0.0133	CbGeAlD
Mirtazapine—HTR3A—brainstem—peripheral nervous system neoplasm	0.00142	0.0129	CbGeAlD
Mirtazapine—HTR2A—nerve—peripheral nervous system neoplasm	0.00133	0.0121	CbGeAlD
Mirtazapine—HTR2A—ganglion—peripheral nervous system neoplasm	0.00132	0.012	CbGeAlD
Mirtazapine—SLC6A3—brainstem—peripheral nervous system neoplasm	0.00118	0.0107	CbGeAlD
Mirtazapine—HTR2C—brainstem—peripheral nervous system neoplasm	0.00114	0.0104	CbGeAlD
Mirtazapine—SLC6A4—brainstem—peripheral nervous system neoplasm	0.00108	0.00983	CbGeAlD
Mirtazapine—HTR1A—brainstem—peripheral nervous system neoplasm	0.000961	0.00873	CbGeAlD
Mirtazapine—ADRA2C—trigeminal ganglion—peripheral nervous system neoplasm	0.000954	0.00866	CbGeAlD
Mirtazapine—SLC6A2—brainstem—peripheral nervous system neoplasm	0.000953	0.00865	CbGeAlD
Mirtazapine—HTR7—brainstem—peripheral nervous system neoplasm	0.000918	0.00834	CbGeAlD
Mirtazapine—OPRK1—cerebellum—peripheral nervous system neoplasm	0.000902	0.00819	CbGeAlD
Mirtazapine—ADRA2C—parotid gland—peripheral nervous system neoplasm	0.000899	0.00817	CbGeAlD
Mirtazapine—ADRA1A—brainstem—peripheral nervous system neoplasm	0.000886	0.00804	CbGeAlD
Mirtazapine—DRD2—brainstem—peripheral nervous system neoplasm	0.000868	0.00788	CbGeAlD
Mirtazapine—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.000775	0.00704	CbGeAlD
Mirtazapine—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.000761	0.00691	CbGeAlD
Mirtazapine—SLC6A3—cerebellum—peripheral nervous system neoplasm	0.000582	0.00529	CbGeAlD
Mirtazapine—HTR2A—brainstem—peripheral nervous system neoplasm	0.000573	0.0052	CbGeAlD
Mirtazapine—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000522	0.00474	CbGeAlD
Mirtazapine—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000474	0.0043	CbGeAlD
Mirtazapine—HTR7—cerebellum—peripheral nervous system neoplasm	0.000453	0.00411	CbGeAlD
Mirtazapine—ADRA1A—cerebellum—peripheral nervous system neoplasm	0.000437	0.00397	CbGeAlD
Mirtazapine—DRD2—cerebellum—peripheral nervous system neoplasm	0.000428	0.00389	CbGeAlD
Mirtazapine—ADRA2C—cerebellum—peripheral nervous system neoplasm	0.000416	0.00378	CbGeAlD
Mirtazapine—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.000332	0.00302	CbGeAlD
Mirtazapine—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000282	0.00256	CbGeAlD
Mirtazapine—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000257	0.00234	CbGeAlD
Mirtazapine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000151	0.000328	CcSEcCtD
Mirtazapine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000151	0.000326	CcSEcCtD
Mirtazapine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000325	CcSEcCtD
Mirtazapine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000324	CcSEcCtD
Mirtazapine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000149	0.000324	CcSEcCtD
Mirtazapine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000149	0.000323	CcSEcCtD
Mirtazapine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000323	CcSEcCtD
Mirtazapine—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000322	CcSEcCtD
Mirtazapine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000321	CcSEcCtD
Mirtazapine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000148	0.000321	CcSEcCtD
Mirtazapine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000148	0.00032	CcSEcCtD
Mirtazapine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.00032	CcSEcCtD
Mirtazapine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000147	0.000319	CcSEcCtD
Mirtazapine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000318	CcSEcCtD
Mirtazapine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000317	CcSEcCtD
Mirtazapine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000146	0.000316	CcSEcCtD
Mirtazapine—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000316	CcSEcCtD
Mirtazapine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000146	0.000316	CcSEcCtD
Mirtazapine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000314	CcSEcCtD
Mirtazapine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000145	0.000314	CcSEcCtD
Mirtazapine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000144	0.000313	CcSEcCtD
Mirtazapine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000312	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000143	0.000311	CcSEcCtD
Mirtazapine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000143	0.000311	CcSEcCtD
Mirtazapine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000143	0.00031	CcSEcCtD
Mirtazapine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000309	CcSEcCtD
Mirtazapine—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000309	CcSEcCtD
Mirtazapine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000142	0.000308	CcSEcCtD
Mirtazapine—Pain—Etoposide—peripheral nervous system neoplasm	0.000142	0.000308	CcSEcCtD
Mirtazapine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000308	CcSEcCtD
Mirtazapine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000308	CcSEcCtD
Mirtazapine—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000307	CcSEcCtD
Mirtazapine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000307	CcSEcCtD
Mirtazapine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000141	0.000305	CcSEcCtD
Mirtazapine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00014	0.000304	CcSEcCtD
Mirtazapine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000303	CcSEcCtD
Mirtazapine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000303	CcSEcCtD
Mirtazapine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000302	CcSEcCtD
Mirtazapine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.0003	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000299	CcSEcCtD
Mirtazapine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000299	CcSEcCtD
Mirtazapine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000299	CcSEcCtD
Mirtazapine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000297	CcSEcCtD
Mirtazapine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000297	CcSEcCtD
Mirtazapine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000137	0.000297	CcSEcCtD
Mirtazapine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000136	0.000296	CcSEcCtD
Mirtazapine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000295	CcSEcCtD
Mirtazapine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000295	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000136	0.000294	CcSEcCtD
Mirtazapine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000136	0.000294	CcSEcCtD
Mirtazapine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000135	0.000293	CcSEcCtD
Mirtazapine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000293	CcSEcCtD
Mirtazapine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000134	0.000291	CcSEcCtD
Mirtazapine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000134	0.000291	CcSEcCtD
Mirtazapine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.00029	CcSEcCtD
Mirtazapine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000134	0.00029	CcSEcCtD
Mirtazapine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000289	CcSEcCtD
Mirtazapine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000133	0.000289	CcSEcCtD
Mirtazapine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000132	0.000286	CcSEcCtD
Mirtazapine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000285	CcSEcCtD
Mirtazapine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000285	CcSEcCtD
Mirtazapine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000285	CcSEcCtD
Mirtazapine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000131	0.000285	CcSEcCtD
Mirtazapine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000131	0.000285	CcSEcCtD
Mirtazapine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000285	CcSEcCtD
Mirtazapine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000285	CcSEcCtD
Mirtazapine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000284	CcSEcCtD
Mirtazapine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000283	CcSEcCtD
Mirtazapine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00013	0.000283	CcSEcCtD
Mirtazapine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00013	0.000282	CcSEcCtD
Mirtazapine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000282	CcSEcCtD
Mirtazapine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000281	CcSEcCtD
Mirtazapine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000281	CcSEcCtD
Mirtazapine—Rash—Vincristine—peripheral nervous system neoplasm	0.000129	0.00028	CcSEcCtD
Mirtazapine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000129	0.00028	CcSEcCtD
Mirtazapine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000129	0.00028	CcSEcCtD
Mirtazapine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000279	CcSEcCtD
Mirtazapine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000279	CcSEcCtD
Mirtazapine—Headache—Vincristine—peripheral nervous system neoplasm	0.000128	0.000278	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000277	CcSEcCtD
Mirtazapine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000276	CcSEcCtD
Mirtazapine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000275	CcSEcCtD
Mirtazapine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000126	0.000274	CcSEcCtD
Mirtazapine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000273	CcSEcCtD
Mirtazapine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000124	0.000269	CcSEcCtD
Mirtazapine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000269	CcSEcCtD
Mirtazapine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000268	CcSEcCtD
Mirtazapine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000266	CcSEcCtD
Mirtazapine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000122	0.000265	CcSEcCtD
Mirtazapine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000265	CcSEcCtD
Mirtazapine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000122	0.000264	CcSEcCtD
Mirtazapine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000264	CcSEcCtD
Mirtazapine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000264	CcSEcCtD
Mirtazapine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000263	CcSEcCtD
Mirtazapine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000262	CcSEcCtD
Mirtazapine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000261	CcSEcCtD
Mirtazapine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.00026	CcSEcCtD
Mirtazapine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000259	CcSEcCtD
Mirtazapine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000119	0.000258	CcSEcCtD
Mirtazapine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000258	CcSEcCtD
Mirtazapine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000258	CcSEcCtD
Mirtazapine—Chills—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000255	CcSEcCtD
Mirtazapine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000118	0.000255	CcSEcCtD
Mirtazapine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000254	CcSEcCtD
Mirtazapine—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000251	CcSEcCtD
Mirtazapine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000115	0.00025	CcSEcCtD
Mirtazapine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000249	CcSEcCtD
Mirtazapine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000249	CcSEcCtD
Mirtazapine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000114	0.000248	CcSEcCtD
Mirtazapine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000114	0.000248	CcSEcCtD
Mirtazapine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000247	CcSEcCtD
Mirtazapine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000114	0.000246	CcSEcCtD
Mirtazapine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000246	CcSEcCtD
Mirtazapine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000245	CcSEcCtD
Mirtazapine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000244	CcSEcCtD
Mirtazapine—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000244	CcSEcCtD
Mirtazapine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000243	CcSEcCtD
Mirtazapine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000242	CcSEcCtD
Mirtazapine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000111	0.00024	CcSEcCtD
Mirtazapine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000239	CcSEcCtD
Mirtazapine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000239	CcSEcCtD
Mirtazapine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00011	0.000238	CcSEcCtD
Mirtazapine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000236	CcSEcCtD
Mirtazapine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000235	CcSEcCtD
Mirtazapine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000108	0.000233	CcSEcCtD
Mirtazapine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000232	CcSEcCtD
Mirtazapine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.00023	CcSEcCtD
Mirtazapine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000229	CcSEcCtD
Mirtazapine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000106	0.000229	CcSEcCtD
Mirtazapine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000229	CcSEcCtD
Mirtazapine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000229	CcSEcCtD
Mirtazapine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000227	CcSEcCtD
Mirtazapine—Rash—Etoposide—peripheral nervous system neoplasm	0.000105	0.000227	CcSEcCtD
Mirtazapine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000105	0.000227	CcSEcCtD
Mirtazapine—Headache—Etoposide—peripheral nervous system neoplasm	0.000104	0.000226	CcSEcCtD
Mirtazapine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000226	CcSEcCtD
Mirtazapine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000225	CcSEcCtD
Mirtazapine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000224	CcSEcCtD
Mirtazapine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000223	CcSEcCtD
Mirtazapine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000222	CcSEcCtD
Mirtazapine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000222	CcSEcCtD
Mirtazapine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000222	CcSEcCtD
Mirtazapine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000221	CcSEcCtD
Mirtazapine—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000221	CcSEcCtD
Mirtazapine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000219	CcSEcCtD
Mirtazapine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000217	CcSEcCtD
Mirtazapine—Cough—Epirubicin—peripheral nervous system neoplasm	9.96e-05	0.000216	CcSEcCtD
Mirtazapine—Convulsion—Epirubicin—peripheral nervous system neoplasm	9.88e-05	0.000214	CcSEcCtD
Mirtazapine—Nausea—Etoposide—peripheral nervous system neoplasm	9.87e-05	0.000214	CcSEcCtD
Mirtazapine—Hypertension—Epirubicin—peripheral nervous system neoplasm	9.85e-05	0.000214	CcSEcCtD
Mirtazapine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	9.79e-05	0.000212	CcSEcCtD
Mirtazapine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	9.76e-05	0.000212	CcSEcCtD
Mirtazapine—Myalgia—Epirubicin—peripheral nervous system neoplasm	9.71e-05	0.000211	CcSEcCtD
Mirtazapine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	9.71e-05	0.000211	CcSEcCtD
Mirtazapine—Chest pain—Epirubicin—peripheral nervous system neoplasm	9.71e-05	0.000211	CcSEcCtD
Mirtazapine—Agitation—Doxorubicin—peripheral nervous system neoplasm	9.7e-05	0.00021	CcSEcCtD
Mirtazapine—Anxiety—Epirubicin—peripheral nervous system neoplasm	9.68e-05	0.00021	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	9.65e-05	0.000209	CcSEcCtD
Mirtazapine—Discomfort—Epirubicin—peripheral nervous system neoplasm	9.6e-05	0.000208	CcSEcCtD
Mirtazapine—Malaise—Doxorubicin—peripheral nervous system neoplasm	9.52e-05	0.000206	CcSEcCtD
Mirtazapine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	9.5e-05	0.000206	CcSEcCtD
Mirtazapine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	9.48e-05	0.000206	CcSEcCtD
Mirtazapine—Syncope—Doxorubicin—peripheral nervous system neoplasm	9.47e-05	0.000205	CcSEcCtD
Mirtazapine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	9.45e-05	0.000205	CcSEcCtD
Mirtazapine—Confusional state—Epirubicin—peripheral nervous system neoplasm	9.39e-05	0.000204	CcSEcCtD
Mirtazapine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	9.33e-05	0.000202	CcSEcCtD
Mirtazapine—Oedema—Epirubicin—peripheral nervous system neoplasm	9.31e-05	0.000202	CcSEcCtD
Mirtazapine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	9.28e-05	0.000201	CcSEcCtD
Mirtazapine—Infection—Epirubicin—peripheral nervous system neoplasm	9.25e-05	0.000201	CcSEcCtD
Mirtazapine—Cough—Doxorubicin—peripheral nervous system neoplasm	9.21e-05	0.0002	CcSEcCtD
Mirtazapine—Shock—Epirubicin—peripheral nervous system neoplasm	9.16e-05	0.000199	CcSEcCtD
Mirtazapine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	9.15e-05	0.000198	CcSEcCtD
Mirtazapine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	9.13e-05	0.000198	CcSEcCtD
Mirtazapine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	9.12e-05	0.000198	CcSEcCtD
Mirtazapine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	9.11e-05	0.000198	CcSEcCtD
Mirtazapine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	9.09e-05	0.000197	CcSEcCtD
Mirtazapine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	9.04e-05	0.000196	CcSEcCtD
Mirtazapine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	9e-05	0.000195	CcSEcCtD
Mirtazapine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	8.99e-05	0.000195	CcSEcCtD
Mirtazapine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	8.99e-05	0.000195	CcSEcCtD
Mirtazapine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	8.99e-05	0.000195	CcSEcCtD
Mirtazapine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	8.96e-05	0.000194	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	8.93e-05	0.000194	CcSEcCtD
Mirtazapine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	8.88e-05	0.000193	CcSEcCtD
Mirtazapine—Anorexia—Epirubicin—peripheral nervous system neoplasm	8.88e-05	0.000192	CcSEcCtD
Mirtazapine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	8.79e-05	0.000191	CcSEcCtD
Mirtazapine—Hypotension—Epirubicin—peripheral nervous system neoplasm	8.7e-05	0.000189	CcSEcCtD
Mirtazapine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	8.69e-05	0.000188	CcSEcCtD
Mirtazapine—Oedema—Doxorubicin—peripheral nervous system neoplasm	8.62e-05	0.000187	CcSEcCtD
Mirtazapine—Infection—Doxorubicin—peripheral nervous system neoplasm	8.56e-05	0.000186	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	8.48e-05	0.000184	CcSEcCtD
Mirtazapine—Shock—Doxorubicin—peripheral nervous system neoplasm	8.48e-05	0.000184	CcSEcCtD
Mirtazapine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	8.45e-05	0.000183	CcSEcCtD
Mirtazapine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	8.44e-05	0.000183	CcSEcCtD
Mirtazapine—Insomnia—Epirubicin—peripheral nervous system neoplasm	8.42e-05	0.000183	CcSEcCtD
Mirtazapine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	8.41e-05	0.000182	CcSEcCtD
Mirtazapine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	8.37e-05	0.000181	CcSEcCtD
Mirtazapine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	8.36e-05	0.000181	CcSEcCtD
Mirtazapine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	8.33e-05	0.000181	CcSEcCtD
Mirtazapine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	8.3e-05	0.00018	CcSEcCtD
Mirtazapine—Somnolence—Epirubicin—peripheral nervous system neoplasm	8.28e-05	0.000179	CcSEcCtD
Mirtazapine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	8.21e-05	0.000178	CcSEcCtD
Mirtazapine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	8.2e-05	0.000178	CcSEcCtD
Mirtazapine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	8.09e-05	0.000175	CcSEcCtD
Mirtazapine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	8.05e-05	0.000175	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	8.04e-05	0.000174	CcSEcCtD
Mirtazapine—Fatigue—Epirubicin—peripheral nervous system neoplasm	8.03e-05	0.000174	CcSEcCtD
Mirtazapine—Constipation—Epirubicin—peripheral nervous system neoplasm	7.96e-05	0.000173	CcSEcCtD
Mirtazapine—Pain—Epirubicin—peripheral nervous system neoplasm	7.96e-05	0.000173	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	7.85e-05	0.00017	CcSEcCtD
Mirtazapine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	7.79e-05	0.000169	CcSEcCtD
Mirtazapine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	7.74e-05	0.000168	CcSEcCtD
Mirtazapine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	7.68e-05	0.000167	CcSEcCtD
Mirtazapine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	7.67e-05	0.000166	CcSEcCtD
Mirtazapine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	7.66e-05	0.000166	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	7.61e-05	0.000165	CcSEcCtD
Mirtazapine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	7.58e-05	0.000164	CcSEcCtD
Mirtazapine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	7.49e-05	0.000162	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	7.44e-05	0.000161	CcSEcCtD
Mirtazapine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	7.43e-05	0.000161	CcSEcCtD
Mirtazapine—Urticaria—Epirubicin—peripheral nervous system neoplasm	7.4e-05	0.00016	CcSEcCtD
Mirtazapine—Constipation—Doxorubicin—peripheral nervous system neoplasm	7.37e-05	0.00016	CcSEcCtD
Mirtazapine—Pain—Doxorubicin—peripheral nervous system neoplasm	7.37e-05	0.00016	CcSEcCtD
Mirtazapine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	7.36e-05	0.00016	CcSEcCtD
Mirtazapine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	7.36e-05	0.00016	CcSEcCtD
Mirtazapine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	7.1e-05	0.000154	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	7.05e-05	0.000153	CcSEcCtD
Mirtazapine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	6.86e-05	0.000149	CcSEcCtD
Mirtazapine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	6.84e-05	0.000148	CcSEcCtD
Mirtazapine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	6.81e-05	0.000148	CcSEcCtD
Mirtazapine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	6.81e-05	0.000148	CcSEcCtD
Mirtazapine—Asthenia—Epirubicin—peripheral nervous system neoplasm	6.68e-05	0.000145	CcSEcCtD
Mirtazapine—Pruritus—Epirubicin—peripheral nervous system neoplasm	6.59e-05	0.000143	CcSEcCtD
Mirtazapine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	6.37e-05	0.000138	CcSEcCtD
Mirtazapine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	6.35e-05	0.000138	CcSEcCtD
Mirtazapine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	6.18e-05	0.000134	CcSEcCtD
Mirtazapine—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.16e-05	0.000133	CcSEcCtD
Mirtazapine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	6.1e-05	0.000132	CcSEcCtD
Mirtazapine—Vomiting—Epirubicin—peripheral nervous system neoplasm	5.92e-05	0.000128	CcSEcCtD
Mirtazapine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	5.89e-05	0.000128	CcSEcCtD
Mirtazapine—Rash—Epirubicin—peripheral nervous system neoplasm	5.87e-05	0.000127	CcSEcCtD
Mirtazapine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	5.87e-05	0.000127	CcSEcCtD
Mirtazapine—Headache—Epirubicin—peripheral nervous system neoplasm	5.83e-05	0.000126	CcSEcCtD
Mirtazapine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	5.7e-05	0.000124	CcSEcCtD
Mirtazapine—Nausea—Epirubicin—peripheral nervous system neoplasm	5.53e-05	0.00012	CcSEcCtD
Mirtazapine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	5.48e-05	0.000119	CcSEcCtD
Mirtazapine—Rash—Doxorubicin—peripheral nervous system neoplasm	5.43e-05	0.000118	CcSEcCtD
Mirtazapine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	5.43e-05	0.000118	CcSEcCtD
Mirtazapine—Headache—Doxorubicin—peripheral nervous system neoplasm	5.4e-05	0.000117	CcSEcCtD
Mirtazapine—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.12e-05	0.000111	CcSEcCtD
Mirtazapine—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.09e-05	0.000192	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.08e-05	0.000191	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.07e-05	0.00019	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.07e-05	0.00019	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.05e-05	0.000189	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.05e-05	0.000188	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	2.03e-05	0.000187	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	2.02e-05	0.000186	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.01e-05	0.000185	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—NRAS—peripheral nervous system neoplasm	2.01e-05	0.000185	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.01e-05	0.000185	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.01e-05	0.000185	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.99e-05	0.000183	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.98e-05	0.000182	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.98e-05	0.000182	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	1.96e-05	0.000181	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.96e-05	0.00018	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.95e-05	0.00018	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—GNAS—peripheral nervous system neoplasm	1.95e-05	0.00018	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.95e-05	0.00018	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.95e-05	0.000179	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	1.94e-05	0.000179	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.93e-05	0.000177	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.92e-05	0.000177	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—ABCB1—peripheral nervous system neoplasm	1.92e-05	0.000176	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.91e-05	0.000176	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	1.9e-05	0.000175	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.9e-05	0.000175	CbGpPWpGaD
Mirtazapine—ADRA2C—Hemostasis—TP53—peripheral nervous system neoplasm	1.89e-05	0.000174	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.87e-05	0.000172	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.86e-05	0.000172	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.82e-05	0.000168	CbGpPWpGaD
Mirtazapine—ADRA2C—Hemostasis—HRAS—peripheral nervous system neoplasm	1.81e-05	0.000167	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.81e-05	0.000167	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.79e-05	0.000165	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.79e-05	0.000165	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.78e-05	0.000164	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.78e-05	0.000164	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.76e-05	0.000162	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.73e-05	0.000159	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.69e-05	0.000155	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.66e-05	0.000153	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	1.66e-05	0.000153	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.66e-05	0.000153	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.66e-05	0.000152	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	1.64e-05	0.000151	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.63e-05	0.00015	CbGpPWpGaD
Mirtazapine—ADRA2C—Hemostasis—AKT1—peripheral nervous system neoplasm	1.6e-05	0.000147	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.58e-05	0.000146	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.57e-05	0.000144	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.56e-05	0.000144	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	1.56e-05	0.000143	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	1.55e-05	0.000143	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	1.54e-05	0.000142	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.54e-05	0.000142	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	1.54e-05	0.000142	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.54e-05	0.000141	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	1.52e-05	0.00014	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.51e-05	0.000139	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.5e-05	0.000138	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.48e-05	0.000136	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.47e-05	0.000136	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.47e-05	0.000136	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	1.47e-05	0.000135	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.47e-05	0.000135	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.46e-05	0.000135	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.46e-05	0.000135	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.45e-05	0.000134	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.44e-05	0.000133	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.44e-05	0.000132	CbGpPWpGaD
Mirtazapine—OPRK1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.43e-05	0.000132	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.42e-05	0.000131	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.42e-05	0.000131	CbGpPWpGaD
Mirtazapine—HTR7—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.41e-05	0.00013	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.41e-05	0.000129	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.4e-05	0.000129	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.4e-05	0.000129	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.4e-05	0.000129	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.39e-05	0.000128	CbGpPWpGaD
Mirtazapine—DRD4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.35e-05	0.000124	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.34e-05	0.000123	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.34e-05	0.000123	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.33e-05	0.000122	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	1.32e-05	0.000122	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.31e-05	0.00012	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.3e-05	0.00012	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	1.3e-05	0.00012	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.29e-05	0.000119	CbGpPWpGaD
Mirtazapine—HTR2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.29e-05	0.000119	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.28e-05	0.000118	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.28e-05	0.000118	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.28e-05	0.000118	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	1.27e-05	0.000117	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.27e-05	0.000117	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.27e-05	0.000117	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.27e-05	0.000117	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	1.26e-05	0.000116	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.25e-05	0.000115	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.25e-05	0.000115	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.24e-05	0.000115	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.24e-05	0.000114	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	1.24e-05	0.000114	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.23e-05	0.000114	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.23e-05	0.000113	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.22e-05	0.000112	CbGpPWpGaD
Mirtazapine—DRD3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.2e-05	0.00011	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.19e-05	0.00011	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.19e-05	0.00011	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.19e-05	0.000109	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.17e-05	0.000108	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.17e-05	0.000108	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.17e-05	0.000107	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.15e-05	0.000106	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.14e-05	0.000105	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.13e-05	0.000104	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.13e-05	0.000104	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.12e-05	0.000103	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.12e-05	0.000103	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.11e-05	0.000102	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.1e-05	0.000102	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.1e-05	0.000101	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.09e-05	0.000101	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.09e-05	0.0001	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.09e-05	0.0001	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.08e-05	9.97e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.08e-05	9.96e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.08e-05	9.92e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.07e-05	9.89e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.07e-05	9.85e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.07e-05	9.84e-05	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.07e-05	9.84e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.06e-05	9.75e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.06e-05	9.73e-05	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.04e-05	9.62e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.04e-05	9.61e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.04e-05	9.57e-05	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.04e-05	9.57e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.04e-05	9.53e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.03e-05	9.52e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.03e-05	9.48e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.02e-05	9.38e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.01e-05	9.31e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1e-05	9.22e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1e-05	9.22e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.97e-06	9.18e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.96e-06	9.17e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.92e-06	9.13e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.85e-06	9.07e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.83e-06	9.05e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.7e-06	8.93e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.65e-06	8.88e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.49e-06	8.74e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.44e-06	8.69e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.44e-06	8.69e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.28e-06	8.55e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.27e-06	8.54e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.26e-06	8.53e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.18e-06	8.45e-05	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.17e-06	8.45e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.1e-06	8.38e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.09e-06	8.37e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.09e-06	8.37e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.07e-06	8.35e-05	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.03e-06	8.31e-05	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.01e-06	8.29e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.96e-06	8.25e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.96e-06	8.25e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.94e-06	8.23e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.92e-06	8.22e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.87e-06	8.17e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.84e-06	8.14e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.76e-06	8.06e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.7e-06	8.01e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.68e-06	7.99e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.63e-06	7.95e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.57e-06	7.89e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.57e-06	7.89e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.45e-06	7.78e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.45e-06	7.78e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.4e-06	7.73e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.33e-06	7.67e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	8.32e-06	7.66e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.27e-06	7.61e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.21e-06	7.56e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.2e-06	7.55e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.2e-06	7.55e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.19e-06	7.54e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.18e-06	7.53e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	8.16e-06	7.51e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.14e-06	7.49e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.08e-06	7.44e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.04e-06	7.4e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.03e-06	7.39e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.83e-06	7.21e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.82e-06	7.2e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.68e-06	7.07e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.62e-06	7.01e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.62e-06	7.01e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.56e-06	6.96e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.5e-06	6.9e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.48e-06	6.89e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.46e-06	6.87e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.34e-06	6.76e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.28e-06	6.71e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.24e-06	6.67e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.1e-06	6.53e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.98e-06	6.43e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.97e-06	6.41e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.94e-06	6.39e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.91e-06	6.36e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.84e-06	6.29e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.82e-06	6.28e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.79e-06	6.25e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.64e-06	6.11e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.64e-06	6.11e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.6e-06	6.08e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.49e-06	5.98e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—AKT1—peripheral nervous system neoplasm	6.49e-06	5.97e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.43e-06	5.92e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.42e-06	5.91e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.35e-06	5.85e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.35e-06	5.84e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.32e-06	5.81e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.14e-06	5.66e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.86e-06	5.4e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.83e-06	5.37e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.73e-06	5.28e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.73e-06	5.28e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.72e-06	5.27e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.62e-06	5.17e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.61e-06	5.16e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.58e-06	5.13e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.57e-06	5.13e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.48e-06	5.05e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.47e-06	5.04e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.42e-06	4.99e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.37e-06	4.94e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	5.27e-06	4.85e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.22e-06	4.8e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.99e-06	4.59e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.92e-06	4.53e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.84e-06	4.46e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.83e-06	4.45e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.74e-06	4.37e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.41e-06	4.06e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	4.18e-06	3.85e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	3.43e-06	3.16e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	3.4e-06	3.13e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	2.91e-06	2.68e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	2.24e-06	2.07e-05	CbGpPWpGaD
